Molecular Mechanism of Avicennia Marina in Inhibiting Hepatitis C Virus Based on Network Pharmacology and Molecular Docking

    Muhammad Arba, Sunandar Ihsan, Nur Fatihah Hasan Nudin, Jamili Jamili
    Image
    Studysummary In this study, researchers using network pharmacology and molecular docking methods found that compounds from Avicennia Marina could inhibit hepatitis C virus infection by targeting key proteins such as AKT1 and TNF-α, showing potential for anti-HCV treatments.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →